Dravet综合征患儿临床表型与神经元钠离子通道&alpha;1亚单位基因突变的相关性分析

张华* 陈海丹 陈泽燕 吴慧莲 唐江利 吴维实 吴仕燕 洪丽

doi:10.16098/j.issn.0529-1356.2018.06.019

PDF(257 KB)

解剖学报 ›› 2018, Vol. 49 ›› Issue (6) : 809-813. DOI: 10.16098/j.issn.0529-1356.2018.06.019

人类学

Dravet综合征患儿临床表型与神经元钠离子通道α1亚单位基因突变的相关性分析

张华* 陈海丹陈泽燕吴慧莲唐江利吴维实吴仕燕洪丽

作者信息 +

Association between the phenotype of Dravet syndrome and sodium channel α1 submit gene mutation

ZHANG Hua* CHEN Hai-dan CHEN Ze-yan WU Hui-lian TANG Jiang-li WU Wei-shi WU Shi-yan HONG Li

Author information +

文章历史 +

摘要

目的探讨神经元钠离子通道α1亚单位（SCN1A）基因突变阳性的Dravet综合征患儿的临床表型特点，从而了解Dravet综合征患儿的病变程度与SCN1A基因突变的相关性。方法回顾性分析2014年1月至2017年1月在海南省农垦三亚医院小儿门诊就诊的43例Dravet综合征患儿及其家系成员的临床资料和SCN1A基因检测结果，以及患儿的心电图、脑电图及核磁共振检查结果。结果 31例Dravet综合征患儿发现SCN1A基因突变阳性，突变类型包括错义突变，移码突变、大片段缺失。SCN1A⁺组患儿发病年龄为（4.32±0.84）月，小于SCN1A^-组（t=2.354；P<0.05）。1岁前月发作频率SCN1A+组为3.24±1.13，而SCN1A^-组为1.77±0.45（t=2.435；P<0.05）。SCN1A⁺组患儿1年内发生癫痫持续状态次数明显高于SCN1A^-组（t=2311；P<0.05）。SCN1A+组中19例患儿出现不同程度的智力减退，而SCN1A-组中3例患儿出现智力减退（P<0.05）。SCN1A⁺组中16例患儿EEG出现背景弥漫性慢波活动，21例为多棘慢波。SCN1A^-组中，2例患儿EEG出现背景弥漫性慢波活动，3例为多棘慢波，两组差异有统计学意义（P<0.05）。结论本研究表明，相比于SCN1A^-组，SCN1A⁺组Dravet综合征患儿发病年龄小，1月前发病次数及平均每年发生癫痫持续状态次数多，智力减退患儿比例大，以及脑电图出现背景弥漫性慢波活动、多棘慢波等异常活动比例大。

Abstract

Objective To investigate the clinical phenotype of children with Dravet syndrome of sodium channel α1 submit gene(SCN1A) mutation, so as to understand the relationship between the degree of lesion and the mutation of SCN1A gene in children with Dravet syndrome. Methods Forty-three children with Dravet syndrome and their family members were analyzed retrospectively from January 2014 to February 2017 in Sanya Hospital, Hainan Province. The clinical records, including SCN1A gene mutation, electrocardiogram（ECG），electroencephalograph（EEG）and nuclear magnetic resonance examination result were collected. Results SCN1A gene mutation was found in 31 cases of Dravet syndrome, including missense mutations, frameshift mutations, and large fragment deletions. The age of onset in the SCN1A⁺ group was (4.32±0.84) months, which was younger than that of the SCN1A^- group (t=2.354;P<0.05). The frequency of onset of SCN1A⁺ was 3.24±1.13 and 1.77±0.45 (t=2.435;P<0.05) in the SCN1A^-group. The number of epileptic seizures in the SCN1A⁺ group was significantly higher than that in the SCN1A- group (t=311;P<0.05). In the SCN1A⁺ group, 19 patients had varous degrees of mental retardation, while in the SCN1A^- group, 3 patients developed mental retardation (P<0.05).In the SCN1A⁺ group, 16 cases of children with EEG background diffused slow wave activity, and 21 cases of multispike slow wave. In the SCN1A^-group, there were statistically significant differences between the two groups (P<0.05).Conclusion Compared with SCN1A^- group, the children in SCN1A⁺ group show younger onset of age, higher frequency of onset and the average number of epilepsy status per year, the poorer intelligence and higher ratio of abnormal activity in EEG.

导出引用

张华陈海丹陈泽燕吴慧莲唐江利吴维实吴仕燕洪丽. Dravet综合征患儿临床表型与神经元钠离子通道α1亚单位基因突变的相关性分析[J]. 解剖学报. 2018, 49(6): 809-813 https://doi.org/10.16098/j.issn.0529-1356.2018.06.019

ZHANG Hua CHEN Hai-dan CHEN Ze-yan WU Hui-lian TANG Jiang-li WU Wei-shi WU Shi-yan HONG Li. Association between the phenotype of Dravet syndrome and sodium channel α1 submit gene mutation[J]. Acta Anatomica Sinica. 2018, 49(6): 809-813 https://doi.org/10.16098/j.issn.0529-1356.2018.06.019

参考文献

［1］Fujiwara T. Clinical spectrum of mutations in SCN1A gene: severe myoclonic epilepsy in infancy and related epilepsies［J］. Epilepsy Res,2006,6(27):S223-S230.

［2］Gataullina S, Dulac O. From genotype to phenotype in Dravet disease［J］. Seizure,2017,2(44):58-64.

［3］Yang L, Wu D, Tang JL.Clinical and molecular genetics of 3 cases of Dravet syndrome［J］. Chinese Journal of Child Health Care, 2016,24(10):1037-1040. (in Chinese)

杨李，吴德，唐久来. Dravet综合征3例临床及分子遗传学研究［J］. 中国儿童保健杂志,2016,24(10):1037-1040.

［4］ Lin XT, Zhang P, Yu DL. Clinical characteristics and genetic type analysis of two cases of Dravet syndrome［J］. Chinese Journal of Birth Health and Heredity, 2015,23(1):119-120,114. (in Chinese)

林晓婷，张萍，于冬丽. 二例Dravet综合征临床特点和基因类型分析［J］. 中国优生与遗传杂志,2015,23(1):119-120,114.

［5］Schutte SS, Schutte RJ, Barragan EV, et al. Model systems for studying cellular mechanisms of SCN1A- related epilepsy［J］. J Neurophysiol,2016,115(4):1755-1766.

［6］Lim BC, Hwang H, Kim H, et al. Epilepsy phenotype associated with a chromosome 2q24.3 deletion involving SCN1A: Migrating partial seizures of infancy or atypical Dravet syndrome［J］? Epilepsy Res,2015,2(109):34-39.

［7］Gontika MP, Konialis C, Pangalos C, et al. Novel SCN1A and GABRA1 gene mutations with diverse phenotypic features and the question on the existence of a broader spectrum of dravet syndrome［J］. Child Neurol Open,2017,5(8):2329048X-17706794X.

［8］Connolly MB. Dravet syndrome: diagnosis and long-term course［J］. Can J Neurol Sci,2016,6(43):S3-S8.

［9］Zhou Q, Zhang Q, Li GQ. Effects of resveratrol on expression of Toll-like receptor 4, nuclear factor-κB and Caspase-3 in hippocampus of seizures in rats［J］. Acta Anatomica Sinica,2014,45(3):321-327. (in Chinese)

周琴，张勤，李光乾. 白藜芦醇对惊厥持续状态大鼠海马Toll样受体4、核因子-κB、Caspase-3表达的影响［J］. 解剖学报,2014,45(3):321-327.

［10］Shmuely S, Sisodiya SM, Gunning WB, et al. Mortality in Dravet syndrome: a review［J］. Epilepsy Behav,2016,64(Pt A):69-74.

［11］Guo JZh, Li YL, Zhong LM, et al. Effect of resveratrol on endogenous mercaptan antioxidant (enzyme) in hippocampus of rats with epilepsy persistence［J］. Acta Anatomica Sinica, 2011,42(5):582-587. (in Chinese)

郭家智，李燕玲，钟莲梅，等. 白藜芦醇调控癫痫持续状态大鼠海马内源性巯醇抗氧化剂(酶)的作用［J］. 解剖学报,2011,42(5):582-587.

［12］Tuncer FN, Gormez Z, Calik M, et al. A clinical variant in SCN1A inherited from a mosaic father cosegregates with a novel variant to cause Dravet syndrome in a consanguineous family［J］. Epilepsy Res,2015,7(113):5-10.

［13］Ni Y, Zhang LM, Wu BB, et al. Clinical analysis of Dravet syndrome and SCNIA gene mutation(report of 60 cases)［J］. Chinese Journal of Practical Pediatrics, 2017,(10):772-776. (in Chinese)

倪燕，张林妹，吴冰冰，等. Dravet综合征临床与SCNIA基因突变分析（附60例报告）［J］. 中国实用儿科杂志，2017,（10）：772-776.

［14］Carvill GL, Weckhuysen S, Mcmahon JM, et al. GABRA1 and STXBP1: novel genetic causes of Dravet syndrome［J］. Neurology,2014,82(14):1245-1253.

［15］Liu A, Xu X, Yang X, et al. The clinical spectrum of female epilepsy patients with PCDH19 mutations in a Chinese population［J］. Clin Genet,2017,91(1):54-62.

［16］Claes L, DelFavero J, Ceulemans B, et al. De novo mutations in the sodium-channel gene SCN1A cause severe myoclonic epilepsy of infancy［J］. Am J Hum Genet,2001,68(6):1327-1332.

［17］Guo JCh, Zhao W. SCN1A gene changes in the incidence of familial febrile seizures［J］. Journal of Clinical Pediatrics, 2017,35(2):133-137. (in Chinese)

郭嘉诚，赵武. SCN1A基因变化在家族性热性惊厥发病中的作用［J］. 临床儿科杂志,2017,35(2):133-137.

［18］Petrelli C, Passamonti C, Cesaroni E, et al. Early clinical features in Dravet syndrome patients with and without SCN1A mutations［J］. Epilepsy Res,2012,99(1-2):21-27.

［19］Wang JW, Shi XY, Kurahashi H, et al. Prevalence of SCN1A mutations in children with suspected Dravet syndrome and intractable childhood epilepsy［J］. Epilepsy Res,2012,102(3):195-200.

［20］Le Gal F, Lebon S, Ramelli GP, et al. When is a child with status epilepticus likely to have Dravet syndrome ［J］ ? Epilepsy Res,2014,108(4):740-747.

［21］Li D, Huang ShP, Song TT, et al. Clinical analysis of children with Dravet syndrome in SCN1A gene mutation［J］. Journal of Xi’an Jiaotong University (Medical Sciences), 2016,37(6):841-845. (in Chinese)

李丹，黄绍平，宋婷婷，等. SCN1A基因突变阳性的Dravet综合征患儿的临床特征分析［J］. 西安交通大学学报(医学版),2016,37(6):841-845.

［22］Ragona F, Brazzo D, De Giorgi Ⅰ, et al. Dravet syndrome: early clinical manifestations and cognitive outcome in 37 Italian patients［J］. Brain Dev,2010,32(1):71-77.

［23］Chen ZhN. Clinical and brain electrocardiogram of Dravet syndrome［J］. Journal of Modern Electrophysiology, 2012,19(1):32-37. (in Chinese)

陈芷若. Dravet综合征的临床和脑心电图［J］. 现代电生理学杂志,2012,19(1):32-37.

［24］Cetica Ⅴ, Chiari S, Mei D, et al. Clinical and genetic factors predicting Dravet syndrome in infants with SCN1A mutations［J］. Neurology,2017,88(11):1037-1044.

［25］Lee HF, Chi CS, Tsai CR, et al. Electroencephalographic features of patients with SCN1A- positive Dravet syndrome［J］. Brain Dev,2015,37(6):599-611.